Please Wait.....
Report
Latin America Halal Pharmaceuticals Market Forecast 2025-2032
Market Reprt I 2025-02-01 I 142 Pages I Inkwood Research
KEY FINDINGS
The Latin America halal pharmaceuticals market is anticipated to rise with a CAGR of 8.68% over the forecast years of 2025 to 2032. In Latin America, countries such as Brazil and Argentina are witnessing an increasing demand for halal-certified healthcare products. This growth can be attributed to the region's expanding trade relationships with Muslim-majority countries and the rise in Muslim populations within urban areas.
MARKET INSIGHTS
Latin American consumers, particularly in metropolitan regions, are not only seeking halal food but also halal pharmaceuticals that align with their ethical, religious, and health considerations. Halal-certified pharmaceuticals, for example, ensure that products are free from alcohol, pork derivatives, or any other prohibited ingredients, making them a popular choice in multicultural markets.
While the halal food sector has been a primary focus for Latin American exporters, the halal pharmaceutical market remains an emerging, untapped opportunity. There is a rising demand for ethical, organic, and non-GMO products, which creates a space for innovative solutions. Latin American pharmaceutical manufacturers can capitalize on this trend by introducing halal-certified versions of common over-the-counter products, supplements, and specialized medications.
Another important aspect of the market is the strengthening of trade relations between Latin American countries and the Gulf Cooperation Council (GCC) nations. The GCC is one of the largest consumers of halal products globally, and Latin American countries are actively working to meet the region's strict halal certification standards.
In this regard, initiatives like halal certification workshops and trade programs are enabling Latin American companies to position themselves as suppliers of high-quality halal pharmaceuticals, boosting exports and tapping into the GCC's growing demand.
REGIONAL ANALYSIS
The Latin America Halal Pharmaceuticals Market growth assessment encompasses a detailed evaluation of Brazil, Mexico, Argentina, and Rest of Latin America.
In Brazil, the halal market benefits from trade agreements with Muslim-majority countries and government-backed initiatives to improve halal certification processes. Similarly, Mexico is expanding its halal industry through trade partnerships and regulatory frameworks aligning with international standards.
However, the market faces challenges, including the complexities of obtaining halal certifications and compliance with stringent regulations. Consumer preferences are shifting toward natural, ethical, and organic products, influencing demand for halal-certified pharmaceuticals. Trends such as the rise in personalized health solutions and the growing acceptance of wellness-oriented products further shape the market.
SEGMENTATION ANALYSIS
The Latin America halal pharmaceuticals market is segmented into drug type, dosage form, and distribution channel. The distribution channel category is further segmented into pharmacies, hospitals, and other distribution channels,
Pharmacies play a pivotal role in offering trusted, regulated healthcare options, and consumers increasingly turn to them for halal alternatives. This trend is particularly prominent in urban areas of Brazil and Mexico, where consumers seek pharmaceuticals that align with their ethical, dietary, and religious values.
In 2021, Mexico saw a notable rise in pharmacies stocking specialized halal products, with a marked demand for halal-certified vitamins and supplements. Consumers prefer pharmacies for their accessibility, convenience, and assurance of product authenticity, as these stores typically adhere to strict regulatory standards.
Furthermore, pharmacies are also becoming platforms for education, with many offering guidance on halal health products. As awareness grows, pharmacies in the region are likely to become key players in the expansion of the halal pharmaceutical market.
COMPETITIVE INSIGHTS
Some of the leading players operating in the Latin America halal pharmaceuticals market include Novartis, Pfizer, Merck, AbbVie, Sanofi, etc.
Novartis, headquartered in Basel, Switzerland, is a global healthcare company that operates through various business segments, including pharmaceuticals, eye care (Alcon), and generics (Sandoz). The company develops and markets a wide range of innovative products, including prescription medications, vaccines, and consumer health products.
In Latin America, Novartis serves numerous countries, including Brazil, Mexico, and Argentina, with a focus on addressing both common and complex health issues. Regarding halal pharmaceuticals, Novartis has developed a portfolio that ensures compliance with halal standards, particularly in markets with significant Muslim populations.
Further, the company's halal-certified products include certain over-the-counter medications, supplements, and injectable formulations, aligning with religious dietary laws and ethical considerations.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. BRAZIL IS THE LEADING EXPORTER OF HALAL-CERTIFIED HEALTHCARE PRODUCTS IN THE REGION
2.5.2. LOCAL PHARMACEUTICAL COMPANIES IN MEXICO ARE ALIGNING PRODUCT PORTFOLIOS TO CATER TO THE HALAL SEGMENT
2.5.3. INCREASING CONSUMER PREFERENCE FOR ETHICAL AND CLEAN-LABEL PRODUCTS
2.5.4. GROWING FOCUS ON BIOLOGICS AND BIOSIMILARS IN HALAL FORMULATIONS IS EXPANDING
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCREASING MUSLIM POPULATION IS DRIVING DEMAND FOR SHARIA-COMPLIANT HEALTHCARE PRODUCTS
3.1.2. RISING AWARENESS ABOUT HALAL CERTIFICATION AMONG CONSUMERS
3.1.3. EXPANSION OF HALAL PHARMACEUTICAL MANUFACTURING IN NON-MUSLIM-MAJORITY COUNTRIES
3.2. KEY RESTRAINTS
3.2.1. HIGH COSTS ASSOCIATED WITH HALAL CERTIFICATION AND COMPLIANCE
3.2.2. LIMITED AVAILABILITY OF HALAL-CERTIFIED RAW MATERIALS
3.2.3. REGULATORY INCONSISTENCIES ACROSS DIFFERENT REGIONS ARE AFFECTING MARKET ENTRY
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS - HALAL
4.2. KEY MARKET TRENDS
4.2.1. GROWING INTEGRATION OF HALAL PHARMACEUTICALS IN GLOBAL SUPPLY CHAINS
4.2.2. INCREASING R&D INVESTMENTS IN HALAL BIOPHARMACEUTICALS
4.2.3. BRAZIL'S HALAL PHARMACEUTICAL EXPORTS ARE INCREASING DUE TO STRATEGIC TRADE RELATIONS WITH MIDDLE EASTERN COUNTRIES
4.2.4. RISING COLLABORATIONS BETWEEN PHARMACEUTICAL COMPANIES AND HALAL CERTIFICATION BODIES
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIAL SOURCING AND CERTIFICATION
4.7.2. RESEARCH AND DEVELOPMENT OF HALAL FORMULATIONS
4.7.3. HALAL-CERTIFIED MANUFACTURING PROCESSES
4.7.4. QUALITY ASSURANCE AND REGULATORY COMPLIANCE
4.7.5. PACKAGING AND LABELING WITH HALAL STANDARDS
4.7.6. DISTRIBUTION AND SUPPLY CHAIN MANAGEMENT
4.7.7. RETAIL AND CONSUMER OUTREACH
4.8. REGULATORY FRAMEWORK AND COMPLIANCE BODIES
5. MARKET BY DRUG TYPE
5.1. ANALGESICS
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. PAIN MANAGEMENT DRUGS
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. ANTI-INFLAMMATORY DRUGS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. RESPIRATORY DRUGS
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. CARDIOVASCULAR DRUGS
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
5.6. VACCINES
5.6.1. MARKET FORECAST FIGURE
5.6.2. SEGMENT ANALYSIS
5.7. OTHER DRUG TYPES
5.7.1. MARKET FORECAST FIGURE
5.7.2. SEGMENT ANALYSIS
6. MARKET BY DOSAGE FORM
6.1. SYRUPS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. CAPSULES
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. TABLETS
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
6.4. POWDERS
6.4.1. MARKET FORECAST FIGURE
6.4.2. SEGMENT ANALYSIS
6.5. OTHER DOSAGE FORMS
6.5.1. MARKET FORECAST FIGURE
6.5.2. SEGMENT ANALYSIS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. PHARMACIES
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITALS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. OTHER DISTRIBUTION CHANNELS
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. LATIN AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. COUNTRY ANALYSIS
8.1.2.1. BRAZIL
8.1.2.1.1. BRAZIL HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.2. MEXICO
8.1.2.2.1. MEXICO HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.3. ARGENTINA
8.1.2.3.1. ARGENTINA HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.4. REST OF LATIN AMERICA
8.1.2.4.1. REST OF LATIN AMERICA HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. BOSCH PHARMACEUTICALS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. CCM PHARMACEUTICALS SDN BHD
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. CHEMICAL COMPANY OF MALAYSIA BHD
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. EMBIL PHARMACEUTICALS CO LTD
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. HOVID
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. MERCK
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. NOOR VITAMINS
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. NOVARTIS
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. NUTRAMEDICAL INCORPORATED
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. PFIZER
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCT LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. PHARMANIAGA BHD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT LIST
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. ROSEMONT PHARMACEUTICALS
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCT LIST
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. SANOFI
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT LIST
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. SIMPOR PHARMA SENDIRIAN BERHAD
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT LIST
9.2.15.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - HALAL PHARMACEUTICALS
TABLE 2: REGULATORY FRAMEWORK AND COMPLIANCE BODIES
TABLE 3: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 4: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DRUG TYPE, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 5: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DOSAGE FORM, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 6: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DOSAGE FORM, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 7: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 8: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 9: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 10: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY COUNTRY, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: MAJOR MARKET FINDINGS
FIGURE 2: MARKET DYNAMICS
FIGURE 3: KEY MARKET TRENDS
FIGURE 4: PORTER'S FIVE FORCES ANALYSIS
FIGURE 5: GROWTH PROSPECT MAPPING
FIGURE 6: MARKET MATURITY ANALYSIS
FIGURE 7: MARKET CONCENTRATION ANALYSIS
FIGURE 8: VALUE CHAIN ANALYSIS
FIGURE 9: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DRUG TYPE, IN 2024
FIGURE 10: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY ANALGESICS, 2025-2032 (IN $ MILLION)
FIGURE 11: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY PAIN MANAGEMENT DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 12: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY ANTI-INFLAMMATORY DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 13: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY RESPIRATORY DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 14: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY CARDIOVASCULAR DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 15: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY VACCINES, 2025-2032 (IN $ MILLION)
FIGURE 16: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY OTHER DRUG TYPES, 2025-2032 (IN $ MILLION)
FIGURE 17: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DOSAGE FORM, IN 2024
FIGURE 18: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY SYRUPS, 2025-2032 (IN $ MILLION)
FIGURE 19: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY CAPSULES, 2025-2032 (IN $ MILLION)
FIGURE 20: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY TABLETS, 2025-2032 (IN $ MILLION)
FIGURE 21: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY POWDERS, 2025-2032 (IN $ MILLION)
FIGURE 22: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY OTHER DOSAGE FORMS, 2025-2032 (IN $ MILLION)
FIGURE 23: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2024
FIGURE 24: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY PHARMACIES, 2025-2032 (IN $ MILLION)
FIGURE 25: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY HOSPITALS, 2025-2032 (IN $ MILLION)
FIGURE 26: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2025-2032 (IN $ MILLION)
FIGURE 27: LATIN AMERICA HALAL PHARMACEUTICALS MARKET, COUNTRY OUTLOOK, 2024 & 2032 (IN %)
FIGURE 28: BRAZIL HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 29: MEXICO HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 30: ARGENTINA HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 31: REST OF LATIN AMERICA HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security